Changing – Talk Bio

CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

14 hours ago talkbio0Tagged 340B, Centers for Medicare and Medicaid Services, Changing, CMS, drug discount program, HHS, Leaked, Policy, Programs - Publication Format, proposal - intent, reorganization, United States Health Resources and Services Administration

340B, Centers for Medicare and Medicaid Services, HHS, reorganization, Programs – Publication Format, proposal – intent, drug discount program, United States Health Resources and Services Administration, CMS, Policy, Leaked, Changing

New NIH grant rules override the Civil Rights Act of 1964, barring recipients from DEI activities

1 day ago talkbio0Tagged 1964, Changing, civil, Civil Rights Act, Condition, Diversity, federal, Israeli (population group), NIH, Policy, Protections, recipients, United States National Institutes of Health

United States National Institutes of Health, recipients, NIH, Policy, Diversity, Changing, Condition, civil, federal, civil, protections, recipients, Israeli (population group), Civil Rights Act, 1964

Immunovant Refines R&D Strategy with New Leadership

2 days ago talkbio0Tagged Changing, Focal, Immunovant, Leadership, Roivant

Immunovant, Roivant, R&D Focus, Leadership Changes, IMVT-1402

Former FDA Officials Sound Alarm: Visible Changes May Be Tip of the Iceberg

7 days ago talkbio0Tagged Alarm device, Changing, Disease Outbreaks, drug safety, Icebergs, KAT5 wt Allele, Leadership, Policy, Previous, public health medicine (field), United States Food and Drug Administration, Vaccines, Visible

United States Food and Drug Administration, public health medicine (field), Changing, Vaccines, Leadership, Policy, drug safety, Previous, KAT5 wt Allele, Icebergs, Disease Outbreaks, Alarm device, Visible

Biopharma Layoff Trends in Q1 2025 and Outlook for Q2

2 weeks ago talkbio0Tagged Biopharma, Biopharma layoffs, Changing, Industry, Legal patent, Pharma, pharmaceutical employment, Q1 2025, Q2 layoff, regulatory, restructuring

Biopharma layoffs, Q1 2025 layoffs, biotech job cuts, pharma workforce reductions, restructuring, patent cliffs, regulatory challenges, Q2 layoff forecast, pharmaceutical employment trends, biopharma industry changes.